Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
16
pubmed:dateCreated
1996-9-12
pubmed:abstractText
Transgenic nonobese diabetic mice were created in which insulin expression was targeted to proopiomelanocortin-expressing pituitary cells. Proopiomelanocortin-expressing intermediate lobe pituitary cells efficiently secrete fully processed, mature insulin via a regulated secretory pathway, similar to islet beta cells. However, in contrast to the insulin-producing islet beta cells, the insulin-producing intermediate lobe pituitaries are not targeted or destroyed by cells of the immune system. Transplantation of the transgenic intermediate lobe tissues into diabetic nonobese diabetic mice resulted in the restoration of near-normoglycemia and the reversal of diabetic symptoms. The absence of autoimmunity in intermediate lobe pituitary cells engineered to secrete bona fide insulin raises the potential of these cell types for beta-cell replacement therapy for the treatment of insulin-dependent diabetes mellitus.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8710916-1309953, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710916-1647029, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710916-1890988, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710916-1988934, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710916-2017186, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710916-2177840, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710916-2184367, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710916-2657740, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710916-2822027, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710916-3017688, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710916-3104603, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710916-3194396, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710916-6245851, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710916-6289132, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710916-6317196, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710916-6337325, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710916-7502038, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710916-7724555, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710916-8056042, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710916-8082534, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710916-8168695, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710916-8267690, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710916-8389457, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710916-8432419, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710916-8440711
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
6
pubmed:volume
93
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
8595-600
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
Insulin-secreting non-islet cells are resistant to autoimmune destruction.
pubmed:affiliation
Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't